We could not find any results for:
Make sure your spelling is correct or try broadening your search.
PAVmed Inc. (Nasdaq:PAVM), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer, will present...
PAVmed Inc. (Nasdaq: PAVM), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer, will...
- Conference Call to be Held August 17th- PAVmed Inc. (Nasdaq:PAVM) (“PAVmed” or the “Company”), a highly-differentiated multi-product medical device company, today announced financial...
PAVmed Inc. (Nasdaq:PAVM), a highly differentiated, multi-product medical device company, today announced that the Company will host a conference call on August 17, 2016 at 4:30 p.m. Eastern...
PAVmed Inc. (Nasdaq:PAVMU), a highly differentiated, multi-product medical device company, announced today that Jan David Wald, Ph.D., Senior Research Analyst at The Benchmark Company, has...
-Common Stock (Nasdaq:PAVM) and Warrants (Nasdaq:PAVMW) will trade separately- -Units (Nasdaq:PAVMU) will cease trading upon separation- PAVmed Inc. (Nasdaq:PAVMU), a highly...
-Commercialization of PortIO™ implantable vascular access device anticipated in 2017- PAVmed Inc. (Nasdaq:PAVMU), a highly differentiated, multi-product medical device company, announced...
- Device designed to revolutionize treatment of Carpal Tunnel Syndrome - - Completely percutaneous procedure would replace invasive surgery - PAVmed Inc. (Nasdaq:PAVMU), an...
- Device designed to revolutionize treatment of Carpal Tunnel Syndrome - - Completely percutaneous procedure would replace invasive surgery - PAVmed Inc. (Nasdaq:PAVMU), an...
PAVmed Inc. (Nasdaq:PAVMU), an innovative, multi-product medical device company developing and commercializing a diversified pipeline of innovative products utilizing a groundbreaking...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions